Status:
TERMINATED
PSYCHIATRIC Disorders and Covid-19
Lead Sponsor:
Nantes University Hospital
Conditions:
Psychiatric Disorder
Covid19
Eligibility:
All Genders
15+ years
Brief Summary
Given the possible risks and complications of a comorbidity between psychiatric disorder and coronavirus disease 2019 (COVID-19), it seems particularly important to specify the impact of the COVID-19 ...
Detailed Description
COVID-19's possible impact on psychiatric disorders has been little studied. However, patients with psychiatric disorders may be at higher risk of COVID-19 contamination, may experience delayed treatm...
Eligibility Criteria
Inclusion
- All patients hospitalized in the PROTECTION COVID-19 PSY unit from the Nantes University Hospital may be included, without maximum age limit.
- Minors, pregnant or nursing women, and patients under guardianship and tutorship may be included, taking into account the study population and the low risks and constraints of the study (observatory)
Exclusion
- minors under 15 years;
- safeguard of justice;
- inability to consent (non-opposition);
- not mastering the reading and writing of the French language well enough.
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 2 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04358042
Start Date
April 24 2020
End Date
July 2 2020
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital - IFAC
Nantes, Loire-Atlantique, France, 44093